The Role of Proteinases in Experimental Asthma
The Role of Proteinases in Experimental Asthma
批准号:
8097277
负责人:
Farrah Kheradmand
金额:
$32.26万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAddressAffinityAllergensAllergicAllergic inflammationAlveolarAsphyxiaAsthmaBindingBiologicalBiological MarkersBronchoalveolar LavageCell surfaceCellsChronicClinicalClinical InvestigatorCollaborationsComplementComplexDevelopmentDiseaseDyspneaEnvironmentEpithelialExhibitsExperimental ModelsExtrinsic asthmaFamilyFunctional disorderFundingGlycosaminoglycansHeparitin SulfateHumanImmuneImmune systemImmunityIn VitroIncidenceIndividualInflammatoryIntegral Membrane ProteinInterleukin-13Interleukin-4Interstitial CollagenaseKnockout MiceKnowledgeLightLinkLiquid substanceLungLung InflammationLung diseasesMMP2 geneMMP9 geneMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMediatingMediator of activation proteinMedicineMetalloproteasesModelingMusObstructive Lung DiseasesPathologicPatientsPeptide HydrolasesPhasePhenotypePlayPrevalenceProteoglycanProteomicsPublic HealthRegulationReportingResolutionRoleSTAT6 geneSamplingSideStructure of parenchyma of lungSurfaceSyndromeT-LymphocyteTestingTh2 CellsUp-RegulationWorkairway inflammationallergic airway inflammationbeta-Chemokineschemokinechemokine receptorcollegecytokineimprovedin vivoinsightmembermouse modelnovelnovel strategiesproteinase Inreceptorresearch studyresponsesyndecantrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Over the last several decades allergic asthma and related atopic syndromes have emerged as major public
health concerns. Studies from around the world suggest that the incidence and prevalence of asthma
began to rise more than two decades ago with no signs that these disturbing trends may be reversing.
Asthma is characterized by episodic dyspnea, lung inflammation, and in some patients, progressive
irreversible airway dysfunction. Experimental models that share many features in common with human
asthma have shed much light on underlying pathologic mechanisms. The central question addressed in this
proposal relates to our discovery that proteinases play distinct roles in development and resolution of
allergic airway inflammation. In particular, the acute phase of allergic inflammation in the lung is
accompanied by increased local proteolytic activity, which we found plays a key role in progression of
experimental asthma. We have shown that several members of the matrix metalloproteinase (MMP) family
show a regulated expression in the lungs of mice that exhibit the asthma phenotype and that this
upregulation is part of the crosstalk between the cytokines released by the inflammatory cell, and certain
types of resident lung parenchymal cells. Further, we show that neither the expression nor biological
activity of MMPs is required for the development of Th2 cells in response to allergen challenge.
Nonetheless, the importance of upregulation of MMPs in allergic lung disease is underscored by our recent
reports showing that mice deficient in MMP2, MMP9 or both show enhanced accumulation of lung
inflammatory cells and are susceptible to asphyxiation when exposed to allergens. Using an acute and
chronic model of asthma, the overall aim of this proposal is to define the role of key MMPs and syndecan-1,
an epithelial proteoglycan in coordinating the crosstalk between immune and non-immune cells in the lung
and in orchestrating the progression of allergic inflammation and clearance of inflammatory cells from lung.
The significance of our studies includes providing insight into the basic mechanism behind progression of
allergic lung inflammation and determining novel molecules that can potentially improve clearance of
airway inflammation. Together these findings will substantially contribute to the understanding of regulation
of Th2 immunity and will provide new approaches for the treatment of asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
-
批准号:10383650
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Farrah Kheradmand
-
依托单位:
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
-
批准号:9774557
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Farrah Kheradmand
-
依托单位:
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
-
批准号:10553621
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Farrah Kheradmand
-
依托单位:
Toxic Effects of Ecigs Following Transition From Conventional Cigarettes
-
批准号:9982334
-
项目类别:
-
资助金额:$44.75万
-
财政年份:2018
-
负责人:Farrah Kheradmand
-
依托单位:
Admin Suppl to examine the role of Vit E Acetate in ENDS
-
批准号:10060130
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2018
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8266804
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8794458
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8604407
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
Ancillary T Cell Based Studies in SPIROMICS
-
批准号:8424239
-
项目类别:
-
资助金额:$39.59万
-
财政年份:2012
-
负责人:Farrah Kheradmand
-
依托单位:
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL: LES COPD
-
批准号:8356768
-
项目类别:
-
资助金额:$6.29万
-
财政年份:2010
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:8195974
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Acquired Immunity in Human COPD and Emphysema
-
批准号:9336809
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Acquired Immunity in Human COPD and Emphysema
-
批准号:8732293
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL: LES COPD
-
批准号:8166763
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:8259372
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:7782707
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Innate and acquired immune responses in human COPD
-
批准号:10225981
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Acquired Immunity in Human COPD and Emphysema
-
批准号:8867863
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
-
批准号:7686519
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Farrah Kheradmand
-
依托单位:
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL
-
批准号:7950688
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2008
-
负责人:Farrah Kheradmand
-
依托单位:
海外基金